Toxicology
Salbutamol / β-Agonist Toxicity
β2-agonist toxicity — tachycardia, tremor, hypokalaemia, hyperglycaemia, lactic acidosis; supportive + cardiac monitoring.
Source: TOXBASE; NPIS
Step 1 of ~2
info
Recognise
Sources:
• Therapeutic excess (high-dose nebulised salbutamol in severe asthma).
• Iatrogenic IV salbutamol.
• Intentional overdose (oral tablets / inhaler abuse).
• Pre-term labour tocolysis.
Features (β2-mediated):
• Cardiac: sinus tachycardia (often >150), palpitations, occasional hypotension, rarely arrhythmia.
• Tremor (β2 in skeletal muscle).
• Hypokalaemia (K shifts intracellularly) — can be severe (<3.0).
• Hyperglycaemia (β2-mediated glycogenolysis + ↓ insulin).
• Lactic acidosis (high-flux glycolysis + adrenergic).
• Anxiety, insomnia, headache.
• Hypoxia paradox in nebuliser-treated asthmatic — pulmonary vasodilation worsens V/Q mismatch.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Hydroxychloroquine (Ophthalmic Toxicity Monitoring) · Antimalarial — Ophthalmic Toxicity Monitoring Drug
- Salbutamol (Paediatric — Asthma/Wheeze) · Short-Acting Beta-2 Agonist (SABA)
- Dexmedetomidine · Alpha-2 Agonist Sedative
- Noradrenaline (Norepinephrine) · Vasopressor (Alpha-1 and Beta-1 Agonist)
- Phenylephrine · Alpha-1 Adrenergic Agonist (Pure Vasoconstrictor)
- Clonidine · Alpha-2 Adrenergic Agonist
Pathways
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014); BNF
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK; BNF
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT; BNF
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT; BNF
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC; BNF
Decision support only. Always apply local guidelines and clinical judgement.